LifeScience Vaccines
Novavax and SII Announce First EUA of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India
Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorized&n...
March 23, 2022 | News
Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules
These experimental results show that Lianhua Qingwen Capsules have significant inhibiting effect on the cytopathic effect induced by Omicron variant so as ...
March 22, 2022 | News
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization ...
March 21, 2022 | News
Novavax Announces Launch of Global Vaccine Education Programs
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
March 11, 2022 | News
Nippon Express USA Acquires GDP Certification for CFS
Inclusive of temporary storage, at temperature-controlled facilities in its CFS near Los Angeles International Airport (effective November 2...
March 09, 2022 | News
Exclusive license for Croda to commercialise SSI’s CAF® vaccine adjuvants
Croda International Plc, which uses smart science to improve lives, announces today that it has entered a strategic collaboration with Statens Serum Instit...
March 04, 2022 | News
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China
According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...
February 21, 2022 | News
TGA Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
"The TGA authorization for the use of our COVID-19 vaccine in children 6-11 years old in Australia is an important milestone for Moderna as it is the first...
February 18, 2022 | News
Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 15, 2022 | News
Kintor Pharma Announces First Patient Dosing in China
Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...
February 14, 2022 | News
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...
February 08, 2022 | News
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 04, 2022 | News
Novavax Submits Request to the U.S. FDA for EUA of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 01, 2022 | News
Australia approves Pfizer booster for 16–17 year olds
The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people aged 16–17 years old. The adv...
January 31, 2022 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
